Viewing Study NCT03873857

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:47 PM
Ignite Modification Date: 2026-01-31 @ 9:20 PM
Study NCT ID: NCT03873857
Status: COMPLETED
Last Update Posted: 2023-09-01
First Post: 2019-03-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Assess Effectiveness of Venclexta (Venetoclax) in Patients With Relapse or Refractory Chronic Lymphocytic Leukemia in Routine Clinical Practice in Russian Federation
Sponsor: AbbVie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia (CLL) View
None Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic Lymphocytic Leukemia (CLL) View
None Cancer View
None Observational Study View
None Venetoclax View
None Relapsed Chronic Lymphocytic Leukemia View
None Refractory Chronic Lymphocytic Leukemia View